Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results.WALTHAM, Mass. -- Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the fourth quarter and fiscal year ended December 31, 2006 on Tuesday, February 27, 2007 prior to the opening of the U.S. financial markets. A conference call will be held at 8:30 a.m. Eastern Time with Steven Rauscher, President and CEO, and other members of Oscient's management team. The Company announced preliminary revenue results for the fourth quarter on January 8, 2007. What: Fourth Quarter Financial Results When: February 27, 2007 at 8:30 am Eastern Time How: Domestic participants can access the call by dialing 1-888-634-4009. International participants are asked to dial 1-706-634-2285. The call will also be webcast through the Company's website at www.oscient.com. A replay will be available two hours after the conclusion of the call until March 6, 2007. Domestic participants can access the replay by dialing 1-800-642-1687, while international participants are asked to dial 1-706-645-9291. The conference ID number for the replay is 8411143. A replay will also be available through www.oscient.com. About Oscient Pharmaceuticals Oscient Pharmaceuticals Corporation is a commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force. ANTARA Antara (äntär`ä), fl. 600, Arab warrior and poet, celebrated in his own day as a hero because he rose from slave birth to be a tribal chief. His poetry is represented by one poem in the Muallaqat. His greatness gave rise to many legends over the centuries, and he became the hero of the popular Arabic epic Sirat Antar.([R]) (fenofibrate fenofibrate /fen·o·fi·brate/ (fen?o-fi´brat) an antihyperlipidemic agent used to reduce elevated serum lipids.) capsules is indicated for the adjunct treatment of hypercholesterolemia familial hypercholesterolemia an inherited disorder of lipoprotein metabolism due to defects in the receptor for low-density lipoprotein (LDL), with xanthomas, corneal arcus, premature corneal atherosclerosis, and a type II-a hyperlipoproteinemia biochemical phenotype with elevated plasma LDL and cholesterol. (high blood cholesterol) and hypertriglyceridemia hypertriglyceridemia /hy·per·tri·glyc·er·i·de·mia/ (-tri-glis?er-i-de´me-ah) an excess of triglycerides in the blood. hy·per·tri·glyc·er·i·de·mi·a (h  (high triglycerides) in combination with diet. FACTIVE([R]) (gemifloxacin mesylate) tablets is an antibiotic approved for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate severity. Oscient also has a novel, late-stage antibiotic candidate, Ramoplanin, under investigation for the treatment of Clostridium difficile-associated disease (CDAD CDAD - Clostridium Difficile-Associated DiarrheaCDAD - Component Data Administrator). For important information regarding the safety and use of ANTARA and FACTIVE, please see the full prescribing information available at www.antararx.com and www.factive.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion